Clinical Trial Update: A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of the investigational agent E6005 in pediatric patients with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• E6005

Snippet

Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED